Literature DB >> 16750787

Abnormal intense skeletal radiotracer uptake on myocardial perfusion imaging with Tc-99m sestamibi.

Archana Gowda1, Lisa Peddinghaus, Vijay Shandilya, Anna Gavriluke, Diwakar Jain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16750787     DOI： 10.1016/j.nuclcard.2006.02.011

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  14 in total

1.  Serendipitous diagnosis of multiple myeloma during sestamibi myocardial perfusion imaging.

Authors:  Jean Lette; Michel Cerino; Stéphane Demaria; Marie-Claire Eybalin; André Levasseur
Journal:  Clin Nucl Med       Date:  2002-11       Impact factor: 7.794

2.  Myocardial perfusion imaging in a patient with chest pain.

Authors:  Gurusher S Panjrath; Kalyani Narra; Diwakar Jain
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

3.  Abnormal photopenic area on nuclear perfusion imaging.

Authors:  Muhammad Raza; Mrinalini Meesala; Gurusher Panjrath; Afshin Ghanbarinia; Diwakar Jain
Journal:  J Nucl Cardiol       Date:  2005 Sep-Oct       Impact factor: 5.952

4.  Unusual radiotracer uptake in the lower mediastinum on sestamibi perfusion images.

Authors:  Muhammad Raza; Mrinalini Meesala; Diwakar Jain
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

5.  Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma.

Authors:  R Fonti; S Del Vecchio; A Zannetti; A De Renzo; F Di Gennaro; L Catalano; C Califano; L Pace; B Rotoli; M Salvatore
Journal:  Eur J Nucl Med       Date:  2001-02

6.  Positive Tc-99m-MIBI scan in a patient with confirmed Paget's disease of bone.

Authors:  Adonios Zanglis; Demetrios Andreopoulos; Athanassios Zissimopoulos; Nikolaos Baziotis
Journal:  Clin Nucl Med       Date:  2005-05       Impact factor: 7.794

7.  99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy.

Authors:  E Alper; M Gurel; T Evrensel; V Ozkocaman; T Akbunar; M Demiray
Journal:  Nucl Med Commun       Date:  2003-05       Impact factor: 1.690

8.  Sestamibi is a substrate for MDR1 and MDR2 P-glycoprotein genes.

Authors:  Brigid Joseph; Kuldeep K Bhargava; Harmeet Malhi; Michael L Schilsky; Diwakar Jain; Christopher J Palestro; Sanjeev Gupta
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-01-21       Impact factor: 9.236

9.  Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma.

Authors:  Rosa Fonti; Silvana Del Vecchio; Antonella Zannetti; Amalia De Renzo; Lucio Catalano; Leonardo Pace; Bruno Rotoli; Marco Salvatore
Journal:  Cancer Biother Radiopharm       Date:  2004-04       Impact factor: 3.099

10.  A comparison of fluorine-18 fluoro-deoxyglucose PET and technetium-99m sestamibi in assessing patients with multiple myeloma.

Authors:  L Mileshkin; R Blum; J F Seymour; A Patrikeos; R J Hicks; H M Prince
Journal:  Eur J Haematol       Date:  2004-01       Impact factor: 2.997
View more
  2 in total

1.  Extracardiac abnormalities on myocardial perfusion imaging in a patient undergoing liver transplantation.

Authors:  Parijat Saurav Joy; Avneesh Chhabra; Afshin Ghanbarinia; Diwakar Jain
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

2.  Bilateral photopenic areas in the lungs on SPECT imaging.

Authors:  Mrinalini Meesala; Muhammad Raza; Vamsee Yaganti; Afshin Ghanbarinia; Gunner Snyder; Diwakar Jain
Journal:  J Nucl Cardiol       Date:  2006-09       Impact factor: 5.952
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.